Jay S. Duker - President and CEO, Director at EyePoint Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jay S. Duker since 12/17/2023

Holdings reported by Jay S. Duker for EyePoint Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 38K $330K $8.69 Jul 10, 2024 Direct
Restricted Stock Units 33.3K $290K $8.69 Jul 10, 2024 Direct Common Stock
Common Stock 22.5K $196K $8.69 Jul 10, 2024 By Family Trust
Stock Option (Right to Buy) 180K Jan 5, 2024 Direct Common Stock

Transactions reported by Jay S. Duker for EyePoint Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.